Atlas Trials

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

Clinical trial NCT04260360 · WITHDRAWN

Trial details

NCT number
NCT04260360
Sponsor
NanOlogy, LLC
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell CarcinomaKidney CancerAdenocarcinoma of KidneyAdenocarcinoma, RenalRenal Cell Cancer
Start date
2020-04-01
Primary completion
2022-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.